News

Orphan drug designation for AIP allows AMT to market in Europe for ten years, following marketing approval for AMT-021 from the European Union. Sander van Deventer, CEO, AMT,

The trial demonstrated that in patients who received PSD502, 91% achieved an IELT of greater than one minute and 75% achieved an IELT of greater than two minutes

The kits will run on a high-throughput multiplex PCR platform which allows processing of large numbers of samples and detecting multiple pathogens in one single run. The highly

The growth in revenue is due to the increase in sales of four of Biostar’s five state approved drugs. The implementation of the Blue Sea project, which markets

DuoPlavin can be taken along with clopidogrel and acetylsalicylic acid for the approved indication of prevention of atherothrombotic events in acute coronary syndrome, said the company. Earlier, the

As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit. “We’re extremely excited to continue with the

The Phase 1, dose-escalation study of MDX-1338 as a monotherapy with chemotherapy is expected to enroll up to 34 patients with relapsed/ refractory AML. Moreover, this trial is

The draft guidance discusses factors that are relevant to the 22 disclosure of risk information and provides numerous examples to illustrate FDA’s thinking on these 23 factors. This

Clinipace will offer technology driven clinical trial services to Inspire including data management, clinical monitoring, site management, regulatory document management, and biostatistical consulting. The trail team will use